万东医疗
(600055)
| 流通市值：76.49亿 | | | 总市值：76.49亿 |
| 流通股本：7.03亿 | | | 总股本：7.03亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 874,647,955.08 | 406,568,573.28 | 1,346,993,071.19 | 1,188,509,072.63 |
| 营业总成本 | 967,898,771.64 | 432,413,033.27 | 1,633,905,567.43 | 1,236,567,549.4 |
| 其他经营收益 | | | | |
| 营业利润 | -93,364,658.19 | -14,692,031.67 | -297,185,224.35 | -21,198,154.19 |
| 利润总额 | -94,344,380.86 | -15,623,754.34 | -300,514,608.35 | -21,198,154.19 |
| 净利润 | -90,501,493.47 | -15,624,126.49 | -227,793,438.06 | -27,546,471.83 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 2,821,150 | - |
| 综合收益总额 | -90,501,493.47 | -15,624,126.49 | -224,972,288.06 | -27,546,471.83 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,090,740,685.51 | 4,235,456,156.73 | 4,605,888,343.4 | 4,645,884,057.69 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,147,969,313.57 | 1,164,981,215.77 | 1,153,236,040.6 | 1,051,764,913.53 |
| 资产总计 | 5,238,709,999.08 | 5,400,437,372.5 | 5,759,124,384 | 5,697,648,971.22 |
| 流动负债: | | | | |
| 流动负债合计 | 685,605,130.4 | 783,553,131.06 | 1,147,865,319.99 | 857,928,201.89 |
| 非流动负债: | | | | |
| 非流动负债合计 | 100,565,351.37 | 64,240,517.13 | 42,991,213.21 | 46,614,314.25 |
| 负债合计 | 786,170,481.77 | 847,793,648.19 | 1,190,856,533.2 | 904,542,516.14 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,340,864,256.6 | 4,441,824,655.12 | 4,457,758,702.42 | 4,683,000,626.85 |
| 股东权益合计 | 4,452,539,517.31 | 4,552,643,724.31 | 4,568,267,850.8 | 4,793,106,455.08 |
| 负债和股东权益合计 | 5,238,709,999.08 | 5,400,437,372.5 | 5,759,124,384 | 5,697,648,971.22 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 957,514,808.11 | 477,278,584.49 | 1,726,874,273.16 | 1,116,630,951.24 |
| 经营活动现金流出小计 | 1,165,700,691.64 | 707,321,368.8 | 1,978,827,513.44 | 1,520,482,956.78 |
| 经营活动产生的现金流量净额 | -208,185,883.53 | -230,042,784.31 | -251,953,240.28 | -403,852,005.54 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 410,294,097.7 | 51,316,620.65 | 2,956,953,287.09 | 765,752,612.22 |
| 投资活动现金流出小计 | 647,959,004.98 | 357,169,463.85 | 2,781,606,316.04 | 1,095,041,391.31 |
| 投资活动产生的现金流量净额 | -237,664,907.28 | -305,852,843.2 | 175,346,971.05 | -329,288,779.09 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 29,867,473.39 | 29,867,473.39 |
| 筹资活动现金流出小计 | 34,279,844.84 | 1,708,298.18 | 127,229,902.13 | 99,979,953.17 |
| 筹资活动产生的现金流量净额 | -34,279,844.84 | -1,708,298.18 | -97,362,428.74 | -70,112,479.78 |
| 汇率变动对现金及现金等价物的影响 | - | - | -9,450,408.73 | - |
| 现金及现金等价物净增加额 | -480,130,635.65 | -537,603,925.69 | -183,419,106.7 | -803,253,264.41 |
| 期末现金及现金等价物余额 | 1,340,892,768.11 | 1,283,419,478.07 | 1,821,023,403.76 | 1,201,189,246.05 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -480,130,635.65 | - | -183,419,106.7 | - |